Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniel D Truong & Erik C Wolters. (2009) Recognition and management of Parkinson’s disease during the premotor (prodromal) phase. Expert Review of Neurotherapeutics 9:6, pages 847-857.
Read now
Read now
Articles from other publishers (22)
Daniel Ho, William Schierding, Sophie L. Farrow, Antony A. Cooper, Andreas W. Kempa-Liehr & Justin M. O’Sullivan. (2022) Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity. Frontiers in Genetics 12.
Crossref
Crossref
Xiaoxue Fu, Yu Wang, Xiaofeng He, Hongyu Li, Hong Liu & Xiangyang Zhang. (2020) A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson’s disease. Lipids in Health and Disease 19:1.
Crossref
Crossref
Yuki Kishimoto, Wandi Zhu, Waki Hosoda, Jyoti M. Sen & Mark P. Mattson. (2019) Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice. NeuroMolecular Medicine 21:3, pages 239-249.
Crossref
Crossref
Wei-Che Lin, Pei-Chin Chen, Chih-Cheng Huang, Nai-Wen Tsai, Hsiu-Ling Chen, Hung-Chen Wang, Kun-Hsien Chou, Meng-Hsiang Chen, Yi-Wen Chen & Cheng-Hsien Lu. (2017) Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson’s Disease. Frontiers in Neurology 8.
Crossref
Crossref
Katri Sääksjärvi, Paul Knekt, Satu Männistö, Jukka Lyytinen & Markku Heliövaara. (2015) Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease. Parkinsonism & Related Disorders 21:10, pages 1148-1155.
Crossref
Crossref
Jung Bin Kim, Byung-Jo Kim, Seong-Beom Koh & Kun-Woo Park. (2014) Autonomic dysfunction according to disease progression in Parkinson's disease. Parkinsonism & Related Disorders 20:3, pages 303-307.
Crossref
Crossref
Eric Aris, Catherine L Dotchin, William K Gray & Richard W Walker. (2013) Autonomic function in a prevalent Tanzanian population with Parkinson’s disease and its relationship to disease duration and 5-year mortality. BMC Research Notes 6:1.
Crossref
Crossref
Kelly Del Tredici & Heiko Braak. (2012) Spinal cord lesions in sporadic Parkinson’s disease. Acta Neuropathologica 124:5, pages 643-664.
Crossref
Crossref
Bernd Müller, Jan Petter Larsen, Tore Wentzel‐Larsen, Geir Olve Skeie & Ole‐Bjørn Tysnes. (2010) Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild. Movement Disorders 26:1, pages 65-72.
Crossref
Crossref
Eduardo Tolosa, Joan Santamaria, Carles Gaig & Yaroslau Compta. 2010. MOVEMENT DISORDERS 4. MOVEMENT DISORDERS 4
229
251
.
Carles Gaig & Eduardo Tolosa. (2009) When does Parkinson's disease begin?. Movement Disorders 24:S2.
Crossref
Crossref
Mark P. Mattson & Ruiqian Wan. (2008) Neurotrophic Factors in Autonomic Nervous System Plasticity and Dysfunction. NeuroMolecular Medicine 10:3, pages 157-168.
Crossref
Crossref
E. Tolosa, Y. Compta & C. Gaig. (2007) The premotor phase of Parkinson's disease. Parkinsonism & Related Disorders 13, pages S2-S7.
Crossref
Crossref
Heiko Braak, Magdalena Sastre, Jürgen R. E. Bohl, Rob A. I. de Vos & Kelly Del Tredici. (2007) Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathologica 113:4, pages 421-429.
Crossref
Crossref
Giulio SciglianoMassimo MusiccoPaola SoliveriImmacolata PiccoloGabriele RonchettiFloriano Girotti. (2006) Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients. Stroke 37:5, pages 1184-1188.
Crossref
Crossref
Alexei Korchounov, Kirn R. Kessler, Nikolay N. Yakhno, Igor V. Damulin & Hayo I. Schipper. (2005) Determinants of autonomic dysfunction in idiopathic Parkinson’s disease. Journal of Neurology 252:12, pages 1530-1536.
Crossref
Crossref
Christiane Magerkurth, Rita Schnitzer & Stefan Braune. (2005) Symptoms of autonomic failure in Parkinson?s disease: prevalence and impact on daily life. Clinical Autonomic Research 15:2, pages 76-82.
Crossref
Crossref
Raymond S. Hurst, Nicole R. Higdon, Judy A. Lawson, Michael A. Clark, Karen L. Rutherford-Root, William G. McDonald, Joseph V. Haas, James P. McGrath & Martin D. Meglasson. (2003) Dopamine receptor agonists differ in their actions on cardiac ion channels. European Journal of Pharmacology 482:1-3, pages 31-37.
Crossref
Crossref
Mike B. Siroky. (2003) Neurological disorders Cerebrovascular disease and Parkinsonism. Urologic Clinics of North America 30:1, pages 27-47.
Crossref
Crossref
M.F Siddiqui, S Rast, M.J Lynn, A.P Auchus & R.F Pfeiffer. (2002) Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism & Related Disorders 8:4, pages 277-284.
Crossref
Crossref
R Djaldetti, E Melamed & N Gadoth. (2001) Abnormal skin wrinkling in the less affected side in hemiparkinsonism – a possible test for sympathetic dysfunction in Parkinson’s disease. Biomedicine & Pharmacotherapy 55:8, pages 475-478.
Crossref
Crossref
Amy Colcher & Tanya Simuni. (1999) CLINICAL MANIFESTATIONS OF PARKINSON'S DISEASE. Medical Clinics of North America 83:2, pages 327-347.
Crossref
Crossref